Acute aortic dissection (AAD) is a clinically “silent,” but emergent and life-threatening cardiovascular disease, and hereditary factors play an important etiologic role in the development of AAD. The purposes of this study are to definitize the diagnostic yield of 59 AAD patients, investigate the molecular pathological spectrum of AAD by NGS, and explore the future preclinical prospects of genetic diagnosis on AAD high-risk groups. We performed next-generation sequencing (NGS) based on screening of the 69 currently aortic dissections/aneurysms-associated genes on 59 sporadic AAD samples from South China. A Kaplan-Meier survival curve was constructed to compare the event-free survival depending on variant number. Overall, 67 variants were detected in 39 patients, among which 4 patients were identified with pathogenic variants and 13 patients were diagnosed with likely pathogenic variants. Seventeen genotype positive patients were identified in aggregate, and the diagnostic yield of our study is 28.8%. All genotype-positive variants were distributed in 11 genes, FBN1 variants were in the largest number among genotype-positive variants, which were detected for 4 times, ACTA2 for 3 times, ABCC6 and TGFBR1 twice, and NOS3, MYLK, XYLT1, TIMP4, TGFBR2, CNTN3, and PON1 once. Individuals with three or more variants showed shorter mean event-free survival than patients with fewer variants. Our observations broaden the genetic pathological spectrum of AAD. Furthermore, our research uncovered two susceptibility genes FBN1 and ACTA2 for Stanford type A AAD patients. Finally, our study concluded that the number of variants an individual harbored was an important consideration in risk stratification for individualized prediction and disease diagnosis.
This is a preview of subscription content, log in to check access.
This work was supported by National Key R&D Program (2017YFC0803502) of China, the Key Program (81430046) from the National Natural Science Foundation of China, and the grant (17ykzd03) from Sun Yat-sen University.
Compliance with ethical standards
All data and sample collection were in strict accordance with ethics guidelines of Zhongshan School of Medicine, Sun Yat-sen University.
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from the healthy controls, patients, or legal representatives of the victims. The principles outlined in the Declaration of Helsinki were followed. The research was approved for human research by the Ethics Committee of Sun Yat-sen University.
Katoh H, Suzuki T, Hiroi Y et al (1995) Diagnosis of aortic dissection by immunoassay for circulating smooth muscle myosin. Lancet 345(8943):191–192CrossRefPubMedGoogle Scholar
Katoh H, Suzuki T, Yokomori K et al (1995) A novel immunoassay of smooth muscle myosin heavy chain in serum. J Immunol Methods 185(1):57–63CrossRefPubMedGoogle Scholar
Suzuki T, Katoh H, Watanabe M et al (1996) Novel biochemical diagnostic method for aortic dissection. Results of a prospective study using an immunoassay of smooth muscle myosin heavy chain. Circulation 93(6):1244–1249CrossRefPubMedGoogle Scholar
Suzuki T, Katoh H, Tsuchio Y et al (2000) Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection. The smooth muscle myosin heavy chain study. Ann Intern Med 133(7):537–541CrossRefPubMedGoogle Scholar
Zhao XL, Chen J, Cui YL, Wu F, Hu DY (2006) Current status of primary hypertension in China: an epidemiological study of 12 provinces, 1 autonomous regions, and 1 municipality. Zhonghua Yi Xue Za Zhi 86(16):1148–1152PubMedGoogle Scholar
Centers for Disease C, Prevention (2013) Racial/ethnic disparities in the awareness, treatment, and control of hypertension - United States, 2003-2010. MMWR Morb Mortal Wkly Rep 62(18):351–355Google Scholar
Hagan PG, Nienaber CA, Isselbacher EM et al (2000) The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA 283(7):897–903CrossRefPubMedGoogle Scholar